Mechanism of diabetic neuropathy: Where are we now and where to go?
Top Cited Papers
Open Access
- 6 October 2010
- journal article
- review article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 2 (1) , 18-32
Abstract
Neuropathy is the most common complication of diabetes. As a consequence of longstanding hyperglycemia, a downstream metabolic cascade leads to peripheral nerve injury through an increased flux of the polyol pathway, enhanced advanced glycation end‐products formation, excessive release of cytokines, activation of protein kinase C and exaggerated oxidative stress, as well as other confounding factors. Although these metabolic aberrations are deemed as the main stream for the pathogenesis of diabetic microvascular complications, organ‐specific histological and biochemical characteristics constitute distinct mechanistic processes of neuropathy different from retinopathy or nephropathy. Extremely long axons originating in the small neuronal body are vulnerable on the most distal side as a result of malnutritional axonal support or environmental insults. Sparse vascular supply with impaired autoregulation is likely to cause hypoxic damage in the nerve. Such dual influences exerted by long‐term hyperglycemia are critical for peripheral nerve damage, resulting in distal‐predominant nerve fiber degeneration. More recently, cellular factors derived from the bone marrow also appear to have a strong impact on the development of peripheral nerve pathology. As evident from such complicated processes, inhibition of single metabolic factors might not be sufficient for the treatment of neuropathy, but a combination of several inhibitors might be a promising approach to overcome this serious disorder. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2010.00070.x, 2010)Keywords
This publication has 164 references indexed in Scilit:
- Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clockJournal of Experimental Medicine, 2009
- Sensory and Motor Peripheral Nerve Function and Lower‐Extremity Quadriceps Strength: The Health, Aging and Body Composition StudyJournal of the American Geriatrics Society, 2009
- Bone Marrow Mononuclear Cells Have Neurovascular Tropism and Improve Diabetic NeuropathyStem Cells, 2009
- Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohortJournal of the Peripheral Nervous System, 2009
- Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long‐term treatment with an aldose reductase inhibitor, epalrestatDiabetic Medicine, 2008
- Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic miceNeuroscience, 2007
- Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cellsFree Radical Biology and Medicine, 2006
- Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cellsBiochemical and Biophysical Research Communications, 2004
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987